InVivo Therapeutics to Present at JMP Securities Annual Life Sciences Conference
June 12 2017 - 8:00AM
Business Wire
InVivo Therapeutics Holdings Corp. (NVIV) today
announced that Mark Perrin, Chief Executive Officer and Chairman,
will present at the JMP Securities Annual Life Sciences Conference
on Tuesday, June 20, 2017 at 2:00 PM Eastern Time at the St. Regis
New York in New York, NY. This is the first time that the Company
has been invited to present at the JMP Securities Annual Life
Sciences Conference. The conference will include company
executives, KOLs, physicians, patients and industry experts
discussing a variety of healthcare topics. Mr. Perrin’s
presentation will highlight recent updates to the Company’s
Neuro-Spinal Scaffold™ program, while providing an overview of the
company.
A live webcast will be available at
http://wsw.com/webcast/jmp33/nviv and a webcast replay will be
available at the same address approximately one hour after the live
webcast presentation. Please log in 5-10 minutes before the event
to ensure a timely connection.
About InVivo Therapeutics
InVivo Therapeutics Holdings Corp. is a research and
clinical-stage biomaterials and biotechnology company with a focus
on treatment of spinal cord injuries. The company was founded in
2005 with proprietary technology co-invented by Robert Langer,
Sc.D., Professor at Massachusetts Institute of Technology, and
Joseph P. Vacanti, M.D., who then was at Boston Children’s Hospital
and who now is affiliated with Massachusetts General Hospital. In
2011, the company earned the David S. Apple Award from the American
Spinal Injury Association for its outstanding contribution to
spinal cord injury medicine. In 2015, the company’s investigational
Neuro-Spinal Scaffold received the 2015 Becker’s Healthcare Spine
Device Award. The publicly-traded company is headquartered in
Cambridge, MA. For more details, visit
www.invivotherapeutics.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170612005332/en/
InVivo TherapeuticsHeather Hamel, 617-863-5530Investor
RelationsInvestor-relations@invivotherapeutics.com
InVivo Therapeutics (NASDAQ:NVIV)
Historical Stock Chart
From Mar 2024 to Apr 2024
InVivo Therapeutics (NASDAQ:NVIV)
Historical Stock Chart
From Apr 2023 to Apr 2024